Matt Windsor
| This email address is being protected from spambots. You need JavaScript enabled to view it.Are your online meetings accessible? If not, here’s what to do.
Accommodations requests from employees and students who are hard of hearing or have vision impairments have increased as meetings and classes move online. Follow these tips to improve your video-based meetings and find out how to access services if you need help.
Interdisciplinary data science workshop moves from San Diego to spare bedrooms, but science continues
Learn how UAB bioinformaticist Jake Chen, Ph.D., and computer scientist Da Yan, Ph.D., shifted their venerable gathering online and aided the fight against COVID-19.
Problem to product: Creating a smart software assistant for researchers and research participants
A faculty member in the School of Health Professions turns his own experiences running research projects into a vision for a comprehensive, automated digital solution with the help of funding from the U.S. Economic Development Administration.
Try these SMART alternatives for your team’s 2021 #goals
OKR and CLEAR are two goal-setting methods that may be better suited for work on teams or groups.
Study testing drug to protect lung cells from ARDS in COVID-19
With funding from UAB’s urgent COVID-19 research grants, researchers are testing penehyclidine to halt the acute respiratory distress syndrome seen in seriously ill patients by defending crucial cell barriers.
Diagnosed or been exposed to COVID-19? New studies are testing desperately needed therapies.
Clinical trials of monoclonal antibodies and convalescent plasma offer new options to outpatients in the first days after a COVID-19 diagnosis.
State of the University town hall: Your questions answered
President Watts and other senior leaders responded to queries on the hiring freeze, student mental health, working from home in 2021 and more.
Problem to product: Targeting SARS-CoV-2 entry into cells
A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.
‘High-risk, high-reward’ NIH grant expands researcher’s work predicting cancer immunotherapy success
Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.
Your ZIP code is a risk factor for COVID-19: Study will identify where testing, therapies are needed most
Using extensive testing, diagnosis and clinical data from across the Deep South, this project will be the first to analyze multiple dimensions of inequality to clarify contributions to COVID-19 disparities.
Help the Graduate School and Staff Council provide much-needed items to the Ronald McDonald House and Birmingham-area schools.
